These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. SARS-CoV-2 pandemic and the need for transplant-oriented trials. Zaza G; Benedetti C; Fribourg M; Maggiore U; Azzi J; Riella LV; Cravedi P Transpl Int; 2020 Aug; 33(8):966-968. PubMed ID: 32333712 [No Abstract] [Full Text] [Related]
4. When the Others Become Us: A Chemist's Perspective of the COVID-19 Outbreak in Italy. Kiessling L; MacLaughlin C; Sattin S ACS Chem Biol; 2020 Jun; 15(6):1279-1281. PubMed ID: 32383582 [No Abstract] [Full Text] [Related]
5. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology. Venkatakrishnan K; Yalkinoglu O; Dong JQ; Benincosa LJ Clin Pharmacol Ther; 2020 Oct; 108(4):699-702. PubMed ID: 32356569 [TBL] [Abstract][Full Text] [Related]
6. Panic prescribing has become omnipresent during the COVID-19 pandemic. Caplan AL; Upshur R J Clin Invest; 2020 Jun; 130(6):2752-2753. PubMed ID: 32330122 [No Abstract] [Full Text] [Related]
7. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy. Stringer KA; Puskarich MA; Kenes MT; Dickson RP Pharmacotherapy; 2020 May; 40(5):382-386. PubMed ID: 32267979 [No Abstract] [Full Text] [Related]
8. Beat COVID-19 through innovation. Azoulay P; Jones B Science; 2020 May; 368(6491):553. PubMed ID: 32381693 [No Abstract] [Full Text] [Related]
9. Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Feldmann M; Maini RN; Woody JN; Holgate ST; Winter G; Rowland M; Richards D; Hussell T Lancet; 2020 May; 395(10234):1407-1409. PubMed ID: 32278362 [No Abstract] [Full Text] [Related]
10. Plant Solutions for the COVID-19 Pandemic and Beyond: Historical Reflections and Future Perspectives. Weng JK Mol Plant; 2020 Jun; 13(6):803-807. PubMed ID: 32442649 [No Abstract] [Full Text] [Related]
11. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic. Shah M; Sachdeva M; Dodiuk-Gad RP Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251 [No Abstract] [Full Text] [Related]
12. Retraction of Studies on Potential Drug Therapies for COVID-19: A Call for Reliability and Scientific Integrity. Guzman-Prado Y Am J Cardiol; 2020 Oct; 132():173. PubMed ID: 32713654 [No Abstract] [Full Text] [Related]
13. Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19. Naci H; Kesselheim AS; Røttingen JA; Salanti G; Vandvik PO; Cipriani A BMJ; 2020 Oct; 371():m3869. PubMed ID: 33067179 [No Abstract] [Full Text] [Related]
14. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Schluger NW Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059 [TBL] [Abstract][Full Text] [Related]
15. Effect of the COVID-19 pandemic on cancer treatment and research. Saini KS; de Las Heras B; de Castro J; Venkitaraman R; Poelman M; Srinivasan G; Saini ML; Verma S; Leone M; Aftimos P; Curigliano G Lancet Haematol; 2020 Jun; 7(6):e432-e435. PubMed ID: 32339482 [No Abstract] [Full Text] [Related]
16. Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity. Fleming TR; Labriola D; Wittes J JAMA; 2020 Jul; 324(1):33-34. PubMed ID: 32463422 [No Abstract] [Full Text] [Related]
18. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research? Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472 [No Abstract] [Full Text] [Related]
20. Optimizing the Trade-off Between Learning and Doing in a Pandemic. Angus DC JAMA; 2020 May; 323(19):1895-1896. PubMed ID: 32227198 [No Abstract] [Full Text] [Related] [Next] [New Search]